Boeck, S, Weigang-Köhler, K, Fuchs, M, Kettner, E, Quietzsch, D, Trojan, J, ...
Background: A standard second-line chemotherapy regimen has yet to be defined for patients with gemcitabine (Gem)-refractory advanced pancreatic cancer (PC). Patients and methods: In this multicenter...
Boeck, S, Weigang-Köhler, K, Fuchs, M, Kettner, E, Quietzsch, D, Trojan, J, ...
Background: A standard second-line chemotherapy regimen has yet to be defined for patients with gemcitabine (Gem)-refractory advanced pancreatic cancer (PC). Patients and methods: In this multicenter...
Boeck, S, Weigang-Köhler, K, Fuchs, M, Kettner, E, Quietzsch, D, Trojan, J, ...
Background: A standard second-line chemotherapy regimen has yet to be defined for patients with gemcitabine (Gem)-refractory advanced pancreatic cancer (PC). Patients and methods: In this multicenter...
Lagging, M., Romero, A.I., Westin, J., Norkrans, G., Dhillon, A.P., Pawlotsky, J.-M., ...
Plasma from 173 patients with HCV genotype 1 infection was analyzed for IP-10 levels prior to treatment with pegylated interferon--2a and ribavirin. Significantly lower IP-10 levels were observed in...
Reesink, H.W., Zeuzem, S., Weegink, C.J., Forestier, N., Vliet, A. Van, Rooij, J. Van De Wetering, ...
Background & Aims: VX-950 specifically inhibits the NS3(.)4A protease of hepatitis C and has antiviral activity in vitro. This phase 1, placebo-controlled, double-blind study evaluated the antiviral...
Herrmann, E., Zeuzem, S., Sarrazin, C., Hinrichsen, H., Benhamou, Y., Manns, M.P., ...
We analysed viral kinetics from a 2-day treatment with BILN 2061, a serine protease inhibitor of hepatitis C virus, in patients chronically infected with genotype 1 hepatitis C virus. The efficiency...
Tang, K.H., Herrmann, E., Cooksley, H., Tatman, N., Chokshi, S., Williams, R., ...
Background/aims: To gain understanding of inter-individual differences of treatment response in hepatitis C virus genotype 1 (HCV-G1) patients, we investigated simultaneously the early HCV kinetics...
Hofmann,W.P., Herrmann,E., Kronenberger,B., Merkwirth,Christian, Welsch,Christian, Lengauer,Thomas, ...
Hofmann, W.P., Herrmann, E., Kronenberger, B., Merkwirth, Christian, Welsch, Christoph, Lengauer, Thomas, ...
Hofmann, W.P., Herrmann, E., Kronenberger, B., Merkwirth, Christian, Welsch, Christian, Lengauer, Thomas, ...
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B (2000)
Carreño, V ; JFA; CORA, Zeuzem, S, Hopf, U, Marcellin, P, Cooksley, W G, Fevery, Johan; U0018702 ;, ...
BACKGROUND/AIMS: Interleukin-12 (IL-12) may be active against hepatitis B virus (HBV). The objective of the study was to assess the tolerability, activity, pharmacokinetics, and pharmacodynamics of...
Zeuzem, S, Feick, P, Zimmermann, P, Haase, W, Kahn, R A, Schulz, I
The ADP-ribosylation factor (ARF), a highly conserved low molecular weight GTP-binding protein, has been implicated to function in intracellular protein transport to and within the Golgi complex. In...
Enzymatic and antisense effects of a specific anti-Ki-ras ribozyme in vitro and in cell culture.
Giannini, C D, Roth, W K, Piiper, A, Zeuzem, S
Due to their mode of action, ribozymes show antisense effects in addition to their specific cleavage activity. In the present study we investigated whether a hammerhead ribozyme is capable of...
Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays.
Roth, W K, Lee, J H, Rüster, B, Zeuzem, S
A quantitative hepatitis C virus reverse transcriptase PCR (HCV RT-PCR) assay established in our laboratory was compared with the Roche Amplicor HCV Monitor test kit for agreement of test results and...
Raedle, J, Brieger, A, Trojan, J, Herrmann, G, Zeuzem, S
In screening for hereditary non-polyposis colorectal cancer (HNPCC)--an autosomal dominant disorder characterised by mutations in mismatch repair genes--detection of microsatellite instability is an...
Piiper, A, Stryjek-Kaminska, D, Jahn, R, Zeuzem, S
Rab3 proteins are localized on secretory vesicles and appear to be involved in regulated exocytosis. We have previously shown that a modified peptide corresponding to the effector domain of the small...
Stryjek-Kaminska, D, Piiper, A, Zeuzem, S
In the present study, Western-blot and radioreceptor analyses have revealed the presence of the epidermal growth factor (EGF) receptor in pancreatic acinar membranes. Isolated pancreatic acinar...
Synthetic peptides containing a BXBXXXB(B) motif activate phospholipase C-beta1.
Piiper, A, Stryjek-Kaminska, D, Illenberger, D, Klengel, R, Schmidt, J M, Gierschik, P, ...
We have recently shown that synthetic peptides of the effector domain of the low-molecular-mass GTP-binding protein Rab3 stimulate inositol 1,4,5-trisphosphate production in various permeabilized...
Zeuzem, S, Feick, P, Zimmermann, P, Haase, W, Kahn, R A, Schulz, I
The ADP-ribosylation factor (ARF), a highly conserved low molecular weight GTP-binding protein, has been implicated to function in intracellular protein transport to and within the Golgi complex. In...
Enzymatic and antisense effects of a specific anti-Ki-ras ribozyme in vitro and in cell culture.
Giannini, C D, Roth, W K, Piiper, A, Zeuzem, S
Due to their mode of action, ribozymes show antisense effects in addition to their specific cleavage activity. In the present study we investigated whether a hammerhead ribozyme is capable of...
Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays.
Roth, W K, Lee, J H, Rüster, B, Zeuzem, S
A quantitative hepatitis C virus reverse transcriptase PCR (HCV RT-PCR) assay established in our laboratory was compared with the Roche Amplicor HCV Monitor test kit for agreement of test results and...
Raedle, J, Brieger, A, Trojan, J, Herrmann, G, Zeuzem, S
In screening for hereditary non-polyposis colorectal cancer (HNPCC)--an autosomal dominant disorder characterised by mutations in mismatch repair genes--detection of microsatellite instability is an...
Piiper, A, Stryjek-Kaminska, D, Jahn, R, Zeuzem, S
Rab3 proteins are localized on secretory vesicles and appear to be involved in regulated exocytosis. We have previously shown that a modified peptide corresponding to the effector domain of the small...
Stryjek-Kaminska, D, Piiper, A, Zeuzem, S
In the present study, Western-blot and radioreceptor analyses have revealed the presence of the epidermal growth factor (EGF) receptor in pancreatic acinar membranes. Isolated pancreatic acinar...
Synthetic peptides containing a BXBXXXB(B) motif activate phospholipase C-beta1.
Piiper, A, Stryjek-Kaminska, D, Illenberger, D, Klengel, R, Schmidt, J M, Gierschik, P, ...
We have recently shown that synthetic peptides of the effector domain of the low-molecular-mass GTP-binding protein Rab3 stimulate inositol 1,4,5-trisphosphate production in various permeabilized...
Perrin, L., Pawlotsky, J. M., Bouvier-Alias, M., Sarrazin, C., Zeuzem, S., Colucci, G.
A TaqMan real-time PCR assay, the COBAS TaqMan human immunodeficiency virus (HIV) (HPS-CTMHIV) PCR assay, recently developed for the quantification of HIV type 1 RNA in plasma, was evaluated in...
Trojan, J, Brieger, A, Raedle, J, Esteller, M, Zeuzem, S
BACKGROUND—In patients with Peutz-Jeghers syndrome (PJS), causative germline mutations in the LKB1/STK11 gene on chromosome 19p13.3 have been identified. Because of the loss of heterozygosity (LOH)...
Brieger, A, Trojan, J, Raedle, J, Plotz, G, Zeuzem, S
Background: Germline mutations in the mismatch repair (MMR) genes hMLH1 and hMSH2 can cause hereditary non-polyposis colorectal cancer (HNPCC). However, the functional in vitro analysis of hMLH1 and...
Stallmach, A, Marth, T, Weiß, B, Wittig, B M, Hombach, A, Schmidt, C, ...
Background and aims: Interleukin-12 (IL-12), a p35/p40 heterodimer, plays a pivotal role in the immune response in Crohn’s disease (CD). Since IL-12 p40 dimers act as IL-12 antagonists, we assayed...
Expert opinion on the treatment of patients with chronic hepatitis C
Zeuzem, S, Berg, T, Moeller, B, Hinrichsen, H, Mauss, S, Wedemeyer, H, ...
The current preferred treatment for patients with hepatitis C virus (HCV) is combination therapy consisting of pegylated interferon alfa and ribavirin (RBV) for 24–48 weeks. Although this approach...